Nexviazyme^{^®}

(avalglucosidase alfa)
Home Infusions for Patients with Pompe Disease

Care for Rare Home Infusion Program

With the Care for Rare Home Infusion Program, patients can enjoy the convenience of having Nexviazyme infusions in the comfort of their home and at a time that suits them by a fully trained infusion nurse. Getting started is simple. Watch this video to learn more.

Nexviazyme Consumer Medicine Information

PBS Information: NEXVIAZYME. This product is not listed on the PBS. This product is funded under the Life Saving Drugs Program.

Please review full Nexviazyme Product Information before prescribing. Full Product Information is available from sanofi-aventis australia pty ltd here or by contacting 1800 818 806.

▼ This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.

Nexviazyme^® is a registered trademark of Sanofi.

MAT-AU-2202849-2.0 - 05/2024.

Nexviazyme^{^®}

Care for Rare Home Infusion Program

You will now be leaving the site

Waddling Gait - Robert, 28-year-old mild LOPD patient

Reaching Overhead - Robert, 28-year-old mild LOPD patient

Standing From Sitting - Robert, 28-year-old mild LOPD patient

Climbing Stairs - Robert, 28-year-old mild LOPD patient

Waddling Gait - Karen, 18-year-old moderate LOPD patient

Reaching Overhead - Karen, 18-year-old moderate LOPD patient

Standing From Sitting - Karen, 18-year-old moderate LOPD patient

Climbing Stairs - Karen, 18-year-old moderate LOPD patient

ASPIRE-ICT-1-23_Harrington_MAT-AU-2302788-1

ASPIRE-ICT-1-23_Kyle-Blakey_MAT-AU-2302789-1

Which biologic and why? When to switch to another one?

Waddling Gait - Brian, 44-year-old severe LOPD patient

Reaching Overhead - Brian, 44-year-old severe LOPD patient

Standing From Sitting - Brian, 44-year-old severe LOPD patient

Climbing Stairs - Brian, 44-year-old severe LOPD patient

RESP-ICT2_Wark_MAT-AU-2301970

RESP-ICT2_Stone_MAT-AU-2301972

Remission in rheumatology - Dr Michelle Tellus

Pavord_MAT-AU-2300571

Wark_MAT-AU-2300572

Q&A-Discussion_MAT-AU-2300573

RESP-ICT3_Tellus_MAT-AU-2302033

RESP-ICT3_Lee_MAT-AU-2302034

RESP-ICT3_Hew_MAT-AU-2302035

RESP-ICT2_Debate_MAT-AU-2301973

RESP-ICT3_Q&A_MAT-AU-2302036

ASPIRE-ICT-1-23_Harrington_MAT-AU-2302788-1

ASPIRE-ICT-1-23_Kyle-Blakey_MAT-AU-2302789-1

Which biologic and why? When to switch to another one?

ASPIRE-ICT1-23_Q&A_MAT-AU-2302791-1

RESP-ICT2_Stone_CS_MAT-AU-2301975

RESP-ICT2_Wark_CS_MAT-AU-2301974

RESP-ICT2_Panel-Discussion_MAT-AU-2301976

RESP-ICT3_Q&A_MAT-AU-2302036

Nexviazyme®

Care for Rare Home Infusion Program

Nexviazyme^{^®}